Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Todd Golub
Dana Farber Cancer Inst, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Foundation Medicine
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Foundation Medicine is involved in the clinical deployment of diagnostic tests for cancer, incorporating genes that are published by others to be relevant in cancer. A reasonable person could conclude that Foundation Medicine could benefit from access to prepublication data from this research.
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
The overarching goals of these studies are the implementation of high throughput technologies that will provide functional information for genes identified as mutated or amplified in glioblastoma, ovarian, colon and pancreatic cancers and the dissemination of this information and validated reagents to the cancer research community. The cancer genes identified using these approaches represent prioritized candidates for investigator-initiated research programs and targets of particular promise for future therapeutic efforts. These studies will leverage prior investments in cancer genome characterization and provide outputs that will facilitate investigator-initiated baic and translational studies and accelerate the development of new therapeutic approaches.
Filed on August 05, 2013.
Tell us what you know about Todd Golub's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Todd Golub filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Todd Golub | Dana Farber Cancer Inst | Conflict of Interest | Foundation Medicine | $60,000 - $79,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.